Low Level Laser Therapy for Traumatic Brain Injury
Abstract
Traumatic Brain Injury or TBIs are common across both military and civilian populations. In the US, the CDC reports an annual TBI incidence of 1.7 million, with 580,000 TBI-associated deaths in the decade 1997-2007. Low-level laser therapy (LLLT) is unique among the many therapies tested clinically for TBI. Its mechanism of action is biostimulation by near-infrared(NIR) light. In the proposed work, through both clinical and preclinical investigations, we plan to further investigate the safety and utility of LLLT for acute TBI.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2015
- Accession Number
- AD1004084
Entities
People
- Benjamin J. Vakoc
Organizations
- Massachusetts General Hospital